Baxter International, Inc. (BAX)
21.58
+0.24
(+1.12%)
USD |
NYSE |
Feb 20, 16:00
21.83
+0.25
(+1.16%)
After-Hours: 20:00
Baxter International Research and Development Expense (Quarterly) : 116.00M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 569.00M |
| ResMed, Inc. | 90.97M |
| Abbott Laboratories | 721.00M |
| Becton, Dickinson & Co. | 306.00M |
| Stryker Corp. | 380.00M |